APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI-driven Peptide Drug Discovery Platform

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global AI-driven Peptide Drug Discovery Platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

5 June 2026198 pages

Choose your research edition.

Industry ResearchAI-driven Peptide Drug Discovery Platform Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal AI-driven Peptide Drug Discovery Platform Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal AI-driven Peptide Drug Discovery Platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI-driven Peptide Drug Discovery Platform Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal AI-driven Peptide Drug Discovery Platform Market Analysis and Forecast 2026-2032257 pages · $4,950 USD

Market perspective

The global AI-driven Peptide Drug Discovery Platform market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for AI-driven Peptide Drug Discovery Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for AI-driven Peptide Drug Discovery Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI-driven Peptide Drug Discovery Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for AI-driven Peptide Drug Discovery Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of AI-driven Peptide Drug Discovery Platform include Peptilogics, Pepticom Ltd, Menten AI, GUBRA, Creative Peptides, Exscalate, Generate Biomedicines, Receptor.AI and Insilico Medicine, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global AI-driven Peptide Drug Discovery Platform market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of AI-driven Peptide Drug Discovery Platform and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents AI-driven Peptide Drug Discovery Platform revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the AI-driven Peptide Drug Discovery Platform market size, projected growth trends, production technologies, key applications, and end-use industries.

AI-driven Peptide Drug Discovery Platform Segment by Company

Peptilogics

Pepticom Ltd

Menten AI

GUBRA

Creative Peptides

Exscalate

Generate Biomedicines

Receptor.AI

Insilico Medicine

Schrödinger

BenevolentAI

Evotec

PeptiFinder

Xtalpi

Sun Novo

Zonsen Peplib Biotech

Tide Tron Biotech

AI-driven Peptide Drug Discovery Platform Segment by Type

Design and Generation Platform

Screening and Optimization Platform

Data-driven Platform

Others

AI-driven Peptide Drug Discovery Platform Segment by Application

Scientific Research

Pharmaceuticals

AI-driven Peptide Drug Discovery Platform Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI-driven Peptide Drug Discovery Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI-driven Peptide Drug Discovery Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI-driven Peptide Drug Discovery Platform.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of AI-driven Peptide Drug Discovery Platform in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI-driven Peptide Drug Discovery Platform industry.

Chapter 3: Detailed analysis of AI-driven Peptide Drug Discovery Platform companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI-driven Peptide Drug Discovery Platformrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global AI-driven Peptide Drug Discovery Platform Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Design and Generation Platform Table 3. Key Players of Screening and Optimization Platform Table 4. Key Players of Data-driven Platform Table 3. Key Players of Others Table 4. Global AI-driven Peptide Drug Discovery Platform Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Scientific Research Table 6. Key Players of Pharmaceuticals Table 7. Global AI-driven Peptide Drug Discovery Platform Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global AI-driven Peptide Drug Discovery Platform Market Size by Region (2021-2026) & (US$ Million) Table 9. Global AI-driven Peptide Drug Discovery Platform Market Share by Region (2021-2026) Table 10. Global AI-driven Peptide Drug Discovery Platform Market Size by Region (2027-2032) & (US$ Million) Table 11. Global AI-driven Peptide Drug Discovery Platform Market Share by Region (2027-2032) Table 12. AI-driven Peptide Drug Discovery Platform Industry Trends Table 13. AI-driven Peptide Drug Discovery Platform Industry Drivers Table 14. AI-driven Peptide Drug Discovery Platform Industry Opportunities and Challenges Table 15. AI-driven Peptide Drug Discovery Platform Industry Restraints Table 16. Global AI-driven Peptide Drug Discovery Platform Revenue by Company (US$ Million) & (2021-2026) Table 17. Global AI-driven Peptide Drug Discovery Platform Revenue Market Share by Company (2021-2026) Table 18. Global AI-driven Peptide Drug Discovery Platform Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global AI-driven Peptide Drug Discovery Platform Key Company Head Office and Area Served Table 20. Global AI-driven Peptide Drug Discovery Platform Company, Product Type & Application Table 21. Global AI-driven Peptide Drug Discovery Platform Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global AI-driven Peptide Drug Discovery Platform by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global AI-driven Peptide Drug Discovery Platform Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global AI-driven Peptide Drug Discovery Platform Market Size by Type (2021-2026) & (US$ Million) Table 26. Global AI-driven Peptide Drug Discovery Platform Market Size by Type (2027-2032) & (US$ Million) Table 27. Global AI-driven Peptide Drug Discovery Platform Revenue Market Share by Type (2021-2026) Table 28. Global AI-driven Peptide Drug Discovery Platform Revenue Market Share by Type (2027-2032) Table 29. Global AI-driven Peptide Drug Discovery Platform Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global AI-driven Peptide Drug Discovery Platform Market Size by Application (2021-2026) & (US$ Million) Table 31. Global AI-driven Peptide Drug Discovery Platform Market Size by Application (2027-2032) & (US$ Million) Table 32. Global AI-driven Peptide Drug Discovery Platform Revenue Market Share by Application (2021-2026) Table 33. Global AI-driven Peptide Drug Discovery Platform Revenue Market Share by Application (2027-2032) Table 34. Peptilogics Company Information Table 35. Peptilogics Business Overview Table 36. Peptilogics AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Peptilogics AI-driven Peptide Drug Discovery Platform Product Portfolio Table 38. Peptilogics Recent Development Table 39. Pepticom Ltd Company Information Table 40. Pepticom Ltd Business Overview Table 41. Pepticom Ltd AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Pepticom Ltd AI-driven Peptide Drug Discovery Platform Product Portfolio Table 43. Pepticom Ltd Recent Development Table 44. Menten AI Company Information Table 45. Menten AI Business Overview Table 46. Menten AI AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Menten AI AI-driven Peptide Drug Discovery Platform Product Portfolio Table 48. Menten AI Recent Development Table 49. GUBRA Company Information Table 50. GUBRA Business Overview Table 51. GUBRA AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. GUBRA AI-driven Peptide Drug Discovery Platform Product Portfolio Table 53. GUBRA Recent Development Table 54. Creative Peptides Company Information Table 55. Creative Peptides Business Overview Table 56. Creative Peptides AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Creative Peptides AI-driven Peptide Drug Discovery Platform Product Portfolio Table 58. Creative Peptides Recent Development Table 59. Exscalate Company Information Table 60. Exscalate Business Overview Table 61. Exscalate AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Exscalate AI-driven Peptide Drug Discovery Platform Product Portfolio Table 63. Exscalate Recent Development Table 64. Generate Biomedicines Company Information Table 65. Generate Biomedicines Business Overview Table 66. Generate Biomedicines AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Generate Biomedicines AI-driven Peptide Drug Discovery Platform Product Portfolio Table 68. Generate Biomedicines Recent Development Table 69. Receptor.AI Company Information Table 70. Receptor.AI Business Overview Table 71. Receptor.AI AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Receptor.AI AI-driven Peptide Drug Discovery Platform Product Portfolio Table 73. Receptor.AI Recent Development Table 74. Insilico Medicine Company Information Table 75. Insilico Medicine Business Overview Table 76. Insilico Medicine AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Insilico Medicine AI-driven Peptide Drug Discovery Platform Product Portfolio Table 78. Insilico Medicine Recent Development Table 79. Schrödinger Company Information Table 80. Schrödinger Business Overview Table 81. Schrödinger AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Schrödinger AI-driven Peptide Drug Discovery Platform Product Portfolio Table 83. Schrödinger Recent Development Table 84. BenevolentAI Company Information Table 85. BenevolentAI Business Overview Table 86. BenevolentAI AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. BenevolentAI AI-driven Peptide Drug Discovery Platform Product Portfolio Table 88. BenevolentAI Recent Development Table 89. Evotec Company Information Table 90. Evotec Business Overview Table 91. Evotec AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 92. Evotec AI-driven Peptide Drug Discovery Platform Product Portfolio Table 93. Evotec Recent Development Table 94. PeptiFinder Company Information Table 95. PeptiFinder Business Overview Table 96. PeptiFinder AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 97. PeptiFinder AI-driven Peptide Drug Discovery Platform Product Portfolio Table 98. PeptiFinder Recent Development Table 99. Xtalpi Company Information Table 100. Xtalpi Business Overview Table 101. Xtalpi AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 102. Xtalpi AI-driven Peptide Drug Discovery Platform Product Portfolio Table 103. Xtalpi Recent Development Table 104. Sun Novo Company Information Table 105. Sun Novo Business Overview Table 106. Sun Novo AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 107. Sun Novo AI-driven Peptide Drug Discovery Platform Product Portfolio Table 108. Sun Novo Recent Development Table 109. Zonsen Peplib Biotech Company Information Table 110. Zonsen Peplib Biotech Business Overview Table 111. Zonsen Peplib Biotech AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 112. Zonsen Peplib Biotech AI-driven Peptide Drug Discovery Platform Product Portfolio Table 113. Zonsen Peplib Biotech Recent Development Table 114. Tide Tron Biotech Company Information Table 115. Tide Tron Biotech Business Overview Table 116. Tide Tron Biotech AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 117. Tide Tron Biotech AI-driven Peptide Drug Discovery Platform Product Portfolio Table 118. Tide Tron Biotech Recent Development Table 119. North America AI-driven Peptide Drug Discovery Platform Market Size by Type (2021-2026) & (US$ Million) Table 120. North America AI-driven Peptide Drug Discovery Platform Market Size by Type (2027-2032) & (US$ Million) Table 121. North America AI-driven Peptide Drug Discovery Platform Market Size by Application (2021-2026) & (US$ Million) Table 122. North America AI-driven Peptide Drug Discovery Platform Market Size by Application (2027-2032) & (US$ Million) Table 123. North America AI-driven Peptide Drug Discovery Platform Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 124. North America AI-driven Peptide Drug Discovery Platform Market Size by Country (2021-2026) Table 125. North America AI-driven Peptide Drug Discovery Platform Market Size by Country (2027-2032) Table 126. Europe AI-driven Peptide Drug Discovery Platform Market Size by Type (2021-2026) & (US$ Million) Table 127. Europe AI-driven Peptide Drug Discovery Platform Market Size by Type (2027-2032) & (US$ Million) Table 128. Europe AI-driven Peptide Drug Discovery Platform Market Size by Application (2021-2026) & (US$ Million) Table 129. Europe AI-driven Peptide Drug Discovery Platform Market Size by Application (2027-2032) & (US$ Million) Table 130. Europe AI-driven Peptide Drug Discovery Platform Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. Europe AI-driven Peptide Drug Discovery Platform Market Size by Country (2021-2026) Table 132. Europe AI-driven Peptide Drug Discovery Platform Market Size by Country (2027-2032) Table 133. China AI-driven Peptide Drug Discovery Platform Market Size by Type (2021-2026) & (US$ Million) Table 134. China AI-driven Peptide Drug Discovery Platform Market Size by Type (2027-2032) & (US$ Million) Table 135. China AI-driven Peptide Drug Discovery Platform Market Size by Application (2021-2026) & (US$ Million) Table 136. China AI-driven Peptide Drug Discovery Platform Market Size by Application (2027-2032) & (US$ Million) Table 137. Asia AI-driven Peptide Drug Discovery Platform Market Size by Type (2021-2026) & (US$ Million) Table 138. Asia AI-driven Peptide Drug Discovery Platform Market Size by Type (2027-2032) & (US$ Million) Table 139. Asia AI-driven Peptide Drug Discovery Platform Market Size by Application (2021-2026) & (US$ Million) Table 140. Asia AI-driven Peptide Drug Discovery Platform Market Size by Application (2027-2032) & (US$ Million) Table 141. Asia AI-driven Peptide Drug Discovery Platform Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. Asia AI-driven Peptide Drug Discovery Platform Market Size by Country (2021-2026) Table 143. Asia AI-driven Peptide Drug Discovery Platform Market Size by Country (2027-2032) Table 144. South America, Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size by Type (2021-2026) & (US$ Million) Table 145. South America, Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size by Type (2027-2032) & (US$ Million) Table 146. South America, Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size by Application (2021-2026) & (US$ Million) Table 147. South America, Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size by Application (2027-2032) & (US$ Million) Table 148. South America, Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 149. South America, Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size by Country (2021-2026) Table 150. South America, Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size by Country (2027-2032) Table 151. Research Programs/Design for This Report Table 152. Authors List of This Report Table 153. Secondary Sources Table 154. Primary Sources List of Figures Figure 1. AI-driven Peptide Drug Discovery Platform Product Image Figure 2. Global AI-driven Peptide Drug Discovery Platform Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global AI-driven Peptide Drug Discovery Platform Market Share by Type: 2025 VS 2032 Figure 4. Design and Generation Platform Image Figure 5. Screening and Optimization Platform Image Figure 6. Data-driven Platform Image Figure 7. Others Image Figure 8. Global AI-driven Peptide Drug Discovery Platform Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global AI-driven Peptide Drug Discovery Platform Market Share by Application: 2025 VS 2032 Figure 10. Scientific Research Image Figure 11. Pharmaceuticals Image Figure 12. Global AI-driven Peptide Drug Discovery Platform Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global AI-driven Peptide Drug Discovery Platform Market Size (2021-2032) & (US$ Million) Figure 14. Global AI-driven Peptide Drug Discovery Platform Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global AI-driven Peptide Drug Discovery Platform Market Share by Players in 2025 Figure 17. Global Top 5 and 10 AI-driven Peptide Drug Discovery Platform Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global AI-driven Peptide Drug Discovery Platform Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global AI-driven Peptide Drug Discovery Platform Revenue Market Share by Type (2021-2032) Figure 21. Global AI-driven Peptide Drug Discovery Platform Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global AI-driven Peptide Drug Discovery Platform Revenue Market Share by Application (2021-2032) Figure 23. North America AI-driven Peptide Drug Discovery Platform Market Size (2021-2032) & (US$ Million) Figure 24. North America AI-driven Peptide Drug Discovery Platform Market Share by Type (2021-2032) Figure 25. North America AI-driven Peptide Drug Discovery Platform Market Share by Application (2021-2032) Figure 26. North America AI-driven Peptide Drug Discovery Platform Market Share by Country (2021-2032) Figure 27. United States AI-driven Peptide Drug Discovery Platform Market Size (2021-2032) & (US$ Million) Figure 28. Canada AI-driven Peptide Drug Discovery Platform Market Size (2021-2032) & (US$ Million) Figure 29. Mexico AI-driven Peptide Drug Discovery Platform Market Size (2021-2032) & (US$ Million) Figure 30. Europe AI-driven Peptide Drug Discovery Platform Market Size (2021-2032) & (US$ Million) Figure 31. Europe AI-driven Peptide Drug Discovery Platform Market Share by Type (2021-2032) Figure 32. Europe AI-driven Peptide Drug Discovery Platform Market Share by Application (2021-2032) Figure 33. Europe AI-driven Peptide Drug Discovery Platform Market Share by Country (2021-2032) Figure 34. Germany AI-driven Peptide Drug Discovery Platform Market Size (2021-2032) & (US$ Million) Figure 35. France AI-driven Peptide Drug Discovery Platform Market Size (2021-2032) & (US$ Million) Figure 36. U.K. AI-driven Peptide Drug Discovery Platform Market Size (2021-2032) & (US$ Million) Figure 37. Italy AI-driven Peptide Drug Discovery Platform Market Size (2021-2032) & (US$ Million) Figure 38. Russia AI-driven Peptide Drug Discovery Platform Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries AI-driven Peptide Drug Discovery Platform Market Size (2021-2032) & (US$ Million) Figure 40. China AI-driven Peptide Drug Discovery Platform Market Size (2021-2032) & (US$ Million) Figure 41. China AI-driven Peptide Drug Discovery Platform Market Share by Type (2021-2032) Figure 42. China AI-driven Peptide Drug Discovery Platform Market Share by Application (2021-2032) Figure 43. Asia AI-driven Peptide Drug Discovery Platform Market Size (2021-2032) & (US$ Million) Figure 44. Asia AI-driven Peptide Drug Discovery Platform Market Share by Type (2021-2032) Figure 45. Asia AI-driven Peptide Drug Discovery Platform Market Share by Application (2021-2032) Figure 46. Asia AI-driven Peptide Drug Discovery Platform Market Share by Country (2021-2032) Figure 47. Japan AI-driven Peptide Drug Discovery Platform Market Size (2021-2032) & (US$ Million) Figure 48. South Korea AI-driven Peptide Drug Discovery Platform Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan AI-driven Peptide Drug Discovery Platform Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia AI-driven Peptide Drug Discovery Platform Market Size (2021-2032) & (US$ Million) Figure 51. India AI-driven Peptide Drug Discovery Platform Market Size (2021-2032) & (US$ Million) Figure 52. Australia AI-driven Peptide Drug Discovery Platform Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Share by Country (2021-2032) Figure 57. Brazil AI-driven Peptide Drug Discovery Platform Market Size (2021-2032) & (US$ Million) Figure 58. South Africa AI-driven Peptide Drug Discovery Platform Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia AI-driven Peptide Drug Discovery Platform Market Size (2021-2032) & (US$ Million) Figure 60. Turkey AI-driven Peptide Drug Discovery Platform Market Size (2021-2032) & (US$ Million) Figure 61. Argentina AI-driven Peptide Drug Discovery Platform Market Size (2021-2032) & (US$ Million) Figure 62. UAE AI-driven Peptide Drug Discovery Platform Market Size (2021-2032) & (US$ Million) Figure 63. Egypt AI-driven Peptide Drug Discovery Platform Market Size (2021-2032) & (US$ Million) Figure 64. Chile AI-driven Peptide Drug Discovery Platform Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Design and Generation Platform
  • Screening and Optimization Platform
  • Data-driven Platform
  • Others
Applications
  • Scientific Research
  • Pharmaceuticals
Companies covered
  • Peptilogics
  • Pepticom Ltd
  • Menten AI
  • GUBRA
  • Creative Peptides
  • Exscalate
  • Generate Biomedicines
  • Receptor.AI
  • Insilico Medicine
  • Schrödinger
  • BenevolentAI
  • Evotec
  • PeptiFinder
  • Xtalpi
  • Sun Novo
  • Zonsen Peplib Biotech
  • Tide Tron Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global AI-driven Peptide Drug Discovery Platform Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Design and Generation Platform
  5. 1.2.3 Screening and Optimization Platform
  6. 1.2.4 Data-driven Platform
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global AI-driven Peptide Drug Discovery Platform Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Scientific Research
  11. 1.3.3 Pharmaceuticals
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global AI-driven Peptide Drug Discovery Platform Growth Trends by Region
  14. 1.5.1 Global AI-driven Peptide Drug Discovery Platform Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 AI-driven Peptide Drug Discovery Platform Market Size by Region (2021-2026)
  16. 1.5.3 AI-driven Peptide Drug Discovery Platform Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global AI-driven Peptide Drug Discovery Platform Market Dynamics
  1. 2.1 AI-driven Peptide Drug Discovery Platform Industry Trends
  2. 2.2 AI-driven Peptide Drug Discovery Platform Industry Drivers
  3. 2.3 AI-driven Peptide Drug Discovery Platform Industry Opportunities and Challenges
  4. 2.4 AI-driven Peptide Drug Discovery Platform Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global AI-driven Peptide Drug Discovery Platform Revenue by Company (2021-2026)
  2. 3.2 Global AI-driven Peptide Drug Discovery Platform Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global AI-driven Peptide Drug Discovery Platform Key Company Head office and Area Served
  4. 3.4 Global AI-driven Peptide Drug Discovery Platform Company, Product Type & Application
  5. 3.5 Global AI-driven Peptide Drug Discovery Platform Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global AI-driven Peptide Drug Discovery Platform Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 AI-driven Peptide Drug Discovery Platform Players Market Share by Revenue in 2025
  9. 3.6.3 2025 AI-driven Peptide Drug Discovery Platform Tier 1, Tier 2, and Tier 3
4 AI-driven Peptide Drug Discovery Platform Market by Type
  1. 4.1 Global AI-driven Peptide Drug Discovery Platform Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global AI-driven Peptide Drug Discovery Platform Market Size by Type (2021-2032)
  3. 4.3 Global AI-driven Peptide Drug Discovery Platform Market Size Share by Type (2021-2032)
5 AI-driven Peptide Drug Discovery Platform Market by Application
  1. 5.1 Global AI-driven Peptide Drug Discovery Platform Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global AI-driven Peptide Drug Discovery Platform Market Size by Application (2021-2032)
  3. 5.3 Global AI-driven Peptide Drug Discovery Platform Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Peptilogics
  2. 6.1.1 Peptilogics Company Information
  3. 6.1.2 Peptilogics Business Overview
  4. 6.1.3 Peptilogics AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Peptilogics AI-driven Peptide Drug Discovery Platform Product Portfolio
  6. 6.1.5 Peptilogics Recent Developments
  7. 6.2 Pepticom Ltd
  8. 6.2.1 Pepticom Ltd Company Information
  9. 6.2.2 Pepticom Ltd Business Overview
  10. 6.2.3 Pepticom Ltd AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Pepticom Ltd AI-driven Peptide Drug Discovery Platform Product Portfolio
  12. 6.2.5 Pepticom Ltd Recent Developments
  13. 6.3 Menten AI
  14. 6.3.1 Menten AI Company Information
  15. 6.3.2 Menten AI Business Overview
  16. 6.3.3 Menten AI AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Menten AI AI-driven Peptide Drug Discovery Platform Product Portfolio
  18. 6.3.5 Menten AI Recent Developments
  19. 6.4 GUBRA
  20. 6.4.1 GUBRA Company Information
  21. 6.4.2 GUBRA Business Overview
  22. 6.4.3 GUBRA AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 GUBRA AI-driven Peptide Drug Discovery Platform Product Portfolio
  24. 6.4.5 GUBRA Recent Developments
  25. 6.5 Creative Peptides
  26. 6.5.1 Creative Peptides Company Information
  27. 6.5.2 Creative Peptides Business Overview
  28. 6.5.3 Creative Peptides AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Creative Peptides AI-driven Peptide Drug Discovery Platform Product Portfolio
  30. 6.5.5 Creative Peptides Recent Developments
  31. 6.6 Exscalate
  32. 6.6.1 Exscalate Company Information
  33. 6.6.2 Exscalate Business Overview
  34. 6.6.3 Exscalate AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Exscalate AI-driven Peptide Drug Discovery Platform Product Portfolio
  36. 6.6.5 Exscalate Recent Developments
  37. 6.7 Generate Biomedicines
  38. 6.7.1 Generate Biomedicines Company Information
  39. 6.7.2 Generate Biomedicines Business Overview
  40. 6.7.3 Generate Biomedicines AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Generate Biomedicines AI-driven Peptide Drug Discovery Platform Product Portfolio
  42. 6.7.5 Generate Biomedicines Recent Developments
  43. 6.8 Receptor.AI
  44. 6.8.1 Receptor.AI Company Information
  45. 6.8.2 Receptor.AI Business Overview
  46. 6.8.3 Receptor.AI AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Receptor.AI AI-driven Peptide Drug Discovery Platform Product Portfolio
  48. 6.8.5 Receptor.AI Recent Developments
  49. 6.9 Insilico Medicine
  50. 6.9.1 Insilico Medicine Company Information
  51. 6.9.2 Insilico Medicine Business Overview
  52. 6.9.3 Insilico Medicine AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Insilico Medicine AI-driven Peptide Drug Discovery Platform Product Portfolio
  54. 6.9.5 Insilico Medicine Recent Developments
  55. 6.10 Schrödinger
  56. 6.10.1 Schrödinger Company Information
  57. 6.10.2 Schrödinger Business Overview
  58. 6.10.3 Schrödinger AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Schrödinger AI-driven Peptide Drug Discovery Platform Product Portfolio
  60. 6.10.5 Schrödinger Recent Developments
  61. 6.11 BenevolentAI
  62. 6.11.1 BenevolentAI Company Information
  63. 6.11.2 BenevolentAI Business Overview
  64. 6.11.3 BenevolentAI AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 BenevolentAI AI-driven Peptide Drug Discovery Platform Product Portfolio
  66. 6.11.5 BenevolentAI Recent Developments
  67. 6.12 Evotec
  68. 6.12.1 Evotec Company Information
  69. 6.12.2 Evotec Business Overview
  70. 6.12.3 Evotec AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Evotec AI-driven Peptide Drug Discovery Platform Product Portfolio
  72. 6.12.5 Evotec Recent Developments
  73. 6.13 PeptiFinder
  74. 6.13.1 PeptiFinder Company Information
  75. 6.13.2 PeptiFinder Business Overview
  76. 6.13.3 PeptiFinder AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 PeptiFinder AI-driven Peptide Drug Discovery Platform Product Portfolio
  78. 6.13.5 PeptiFinder Recent Developments
  79. 6.14 Xtalpi
  80. 6.14.1 Xtalpi Company Information
  81. 6.14.2 Xtalpi Business Overview
  82. 6.14.3 Xtalpi AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Xtalpi AI-driven Peptide Drug Discovery Platform Product Portfolio
  84. 6.14.5 Xtalpi Recent Developments
  85. 6.15 Sun Novo
  86. 6.15.1 Sun Novo Company Information
  87. 6.15.2 Sun Novo Business Overview
  88. 6.15.3 Sun Novo AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Sun Novo AI-driven Peptide Drug Discovery Platform Product Portfolio
  90. 6.15.5 Sun Novo Recent Developments
  91. 6.16 Zonsen Peplib Biotech
  92. 6.16.1 Zonsen Peplib Biotech Company Information
  93. 6.16.2 Zonsen Peplib Biotech Business Overview
  94. 6.16.3 Zonsen Peplib Biotech AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Zonsen Peplib Biotech AI-driven Peptide Drug Discovery Platform Product Portfolio
  96. 6.16.5 Zonsen Peplib Biotech Recent Developments
  97. 6.17 Tide Tron Biotech
  98. 6.17.1 Tide Tron Biotech Company Information
  99. 6.17.2 Tide Tron Biotech Business Overview
  100. 6.17.3 Tide Tron Biotech AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Tide Tron Biotech AI-driven Peptide Drug Discovery Platform Product Portfolio
  102. 6.17.5 Tide Tron Biotech Recent Developments
7 North America
  1. 7.1 North America AI-driven Peptide Drug Discovery Platform Market Size (2021-2032)
  2. 7.2 North America AI-driven Peptide Drug Discovery Platform Market Size by Type
  3. 7.2.1 North America AI-driven Peptide Drug Discovery Platform Market Size by Type (2021-2026)
  4. 7.2.2 North America AI-driven Peptide Drug Discovery Platform Market Size by Type (2027-2032)
  5. 7.2.3 North America AI-driven Peptide Drug Discovery Platform Market Share by Type (2021-2032)
  6. 7.3 North America AI-driven Peptide Drug Discovery Platform Market Size by Application
  7. 7.3.1 North America AI-driven Peptide Drug Discovery Platform Market Size by Application (2021-2026)
  8. 7.3.2 North America AI-driven Peptide Drug Discovery Platform Market Size by Application (2027-2032)
  9. 7.3.3 North America AI-driven Peptide Drug Discovery Platform Market Share by Application (2021-2032)
  10. 7.4 North America AI-driven Peptide Drug Discovery Platform Market Size by Country
  11. 7.4.1 North America AI-driven Peptide Drug Discovery Platform Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America AI-driven Peptide Drug Discovery Platform Market Size by Country (2021-2026)
  13. 7.4.3 North America AI-driven Peptide Drug Discovery Platform Market Size by Country (2027-2032)
  14. 7.4.4 North America AI-driven Peptide Drug Discovery Platform Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe AI-driven Peptide Drug Discovery Platform Market Size (2021-2032)
  2. 8.2 Europe AI-driven Peptide Drug Discovery Platform Market Size by Type
  3. 8.2.1 Europe AI-driven Peptide Drug Discovery Platform Market Size by Type (2021-2026)
  4. 8.2.2 Europe AI-driven Peptide Drug Discovery Platform Market Size by Type (2027-2032)
  5. 8.2.3 Europe AI-driven Peptide Drug Discovery Platform Market Share by Type (2021-2032)
  6. 8.3 Europe AI-driven Peptide Drug Discovery Platform Market Size by Application
  7. 8.3.1 Europe AI-driven Peptide Drug Discovery Platform Market Size by Application (2021-2026)
  8. 8.3.2 Europe AI-driven Peptide Drug Discovery Platform Market Size by Application (2027-2032)
  9. 8.3.3 Europe AI-driven Peptide Drug Discovery Platform Market Share by Application (2021-2032)
  10. 8.4 Europe AI-driven Peptide Drug Discovery Platform Market Size by Country
  11. 8.4.1 Europe AI-driven Peptide Drug Discovery Platform Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe AI-driven Peptide Drug Discovery Platform Market Size by Country (2021-2026)
  13. 8.4.3 Europe AI-driven Peptide Drug Discovery Platform Market Size by Country (2027-2032)
  14. 8.4.4 Europe AI-driven Peptide Drug Discovery Platform Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China AI-driven Peptide Drug Discovery Platform Market Size (2021-2032)
  2. 9.2 China AI-driven Peptide Drug Discovery Platform Market Size by Type
  3. 9.2.1 China AI-driven Peptide Drug Discovery Platform Market Size by Type (2021-2026)
  4. 9.2.2 China AI-driven Peptide Drug Discovery Platform Market Size by Type (2027-2032)
  5. 9.2.3 China AI-driven Peptide Drug Discovery Platform Market Share by Type (2021-2032)
  6. 9.3 China AI-driven Peptide Drug Discovery Platform Market Size by Application
  7. 9.3.1 China AI-driven Peptide Drug Discovery Platform Market Size by Application (2021-2026)
  8. 9.3.2 China AI-driven Peptide Drug Discovery Platform Market Size by Application (2027-2032)
  9. 9.3.3 China AI-driven Peptide Drug Discovery Platform Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia AI-driven Peptide Drug Discovery Platform Market Size (2021-2032)
  2. 10.2 Asia AI-driven Peptide Drug Discovery Platform Market Size by Type
  3. 10.2.1 Asia AI-driven Peptide Drug Discovery Platform Market Size by Type (2021-2026)
  4. 10.2.2 Asia AI-driven Peptide Drug Discovery Platform Market Size by Type (2027-2032)
  5. 10.2.3 Asia AI-driven Peptide Drug Discovery Platform Market Share by Type (2021-2032)
  6. 10.3 Asia AI-driven Peptide Drug Discovery Platform Market Size by Application
  7. 10.3.1 Asia AI-driven Peptide Drug Discovery Platform Market Size by Application (2021-2026)
  8. 10.3.2 Asia AI-driven Peptide Drug Discovery Platform Market Size by Application (2027-2032)
  9. 10.3.3 Asia AI-driven Peptide Drug Discovery Platform Market Share by Application (2021-2032)
  10. 10.4 Asia AI-driven Peptide Drug Discovery Platform Market Size by Country
  11. 10.4.1 Asia AI-driven Peptide Drug Discovery Platform Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia AI-driven Peptide Drug Discovery Platform Market Size by Country (2021-2026)
  13. 10.4.3 Asia AI-driven Peptide Drug Discovery Platform Market Size by Country (2027-2032)
  14. 10.4.4 Asia AI-driven Peptide Drug Discovery Platform Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size by Type
  3. 11.2.1 South America, Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size by Application
  7. 11.3.1 South America, Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size by Country
  11. 11.4.1 South America, Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst